Life Sciences Transformational R&D Investment Fund (TRIF) Pilot

The Life Sciences Transformational R&D Investment Fund Pilot offers capital grants to support large-scale R&D projects in the UK life sciences sector. This newly established £50 million fund aims to boost research and development within the UK's Life Sciences sector by supporting large-scale investments focused on innovation and strengthening health resilience. Projects must exceed £100 million in total costs to be eligible. The fund prioritises projects with the potential to generate economic benefits, including substantial contributions to Gross Value Added (GVA), creation of high-wage, high-skilled jobs, and generating R&D spillover benefits. This fund complements the separate Life Sciences Innovative Manufacturing Fund (LSIMF) and supports projects in human medicines, medical diagnostics, and MedTech products. The grant is set at the minimum level necessary to ensure projects proceed while adhering to UK subsidy regulations, typically ranging from 10-20% of total project costs.